Leading international accelerator VC, Accelerating Asia, has officially announced the fourth cohort of its flagship 100-day program for pre-Series A startups.

The 11 startups have raised over S$6 million coming into the programme, bringing the total capital raised by Accelerating Asia’s startups to over S$30 million, with 70 percent of investment raised since joining the Accelerating Asia portfolio.

Amra Naidoo, Co-Founder and General Partner of Accelerating Asia, said, “We’ve selected cohort four from 500 startups from 30 countries, a record number of applications for us that shows the demand for a Singapore based accelerator with an international footprint. With just 2 percent of startups selected, the chosen 11 will be part of our largest cohort and are eligible to receive up to S$200,000 in investment from our VC fund.”

Out of the 11 startups, 3 are catering to the healthcare sector-

Amar Lab, from Bangladesh, partners with top local and international diagnostic labs to provide end to end diagnostics test services from sample collection to testing to report delivery directly from customers premises, saving time, money and hassle for patients. To date Amar Lab has served over 10,000 diagnostic tests and is providing COVID tests for individuals and corporate clients.

DoctorKoi is a healthtech company offering a prescription writing software that allows a doctor to write a prescription from a database of 27,000 medications within just a few clicks. DoctorKoi works with over 1300 doctors, partners with top pharmaceutical companies and has processed over 2.6M digital prescriptions.

Mobiliti provides state of the art bionic lower limb prosthetics at affordable prices. Mobiliti has already served over 1000 patients and established a partnership with the International Committee of the Red Cross.